Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer

Bioscience Reports

Volumn 33, Issue 4, 2013, Pages 637-643

  Chini, Eduardo Nunes ^a   Chini, Claudia C S ^a   Nin, Veronica ^a   Escande, Carlos ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Aging; Cancer; Circadian cycle; Deleted in breast cancer 1 (DBC1); Epigenetics; Histone deacetylase (HDAC); Metabolism

Indexed keywords

CELL NUCLEUS RECEPTOR; DELETED IN BREAST CANCER 1 PROTEIN; HISTONE DEACETYLASE 3; HISTONE METHYLTRANSFERASE; NUCLEAR PROTEIN; NUCLEAR RECEPTOR NR1D1; NUDIX HYDROLASE; RNA BINDING PROTEIN; SIRTUIN 1; SUV39H1 PROTEIN; UNCLASSIFIED DRUG; DBC1 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE; TUMOR SUPPRESSOR PROTEIN;

AGING; CELL METABOLISM; CHROMOSOME 8P; DELETED IN BREAST CANCER 1 GENE; DIABETES MELLITUS; DNA METHYLATION; ENERGY METABOLISM; EPIGENETICS; GENE; GENE DELETION; HISTONE ACETYLATION; HUMAN; METABOLIC REGULATION; METABOLISM; NEOPLASM; NONHUMAN; OBESITY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SPLICEOSOME; ANIMAL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; PHYSIOLOGY; PROTEIN PROCESSING;

AGING; ANIMALS; ENERGY METABOLISM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HISTONES; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPLICEOSOMES; TUMOR SUPPRESSOR PROTEINS;

EID: 84883754518     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20130062     Document Type: Review

References (57)

1. Hamaguchi, M. et al. (2002) DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 99, 13647-13652 (Pubitemid 35215435)
2. Kim, J. E., Chen, J. and Lou, Z. (2009) p30 DBC is a potential regulator of tumorigenesis. Cell Cycle 8, 2932-2935
3. Di Marcotullio, L., Canettieri, G., Infante, P., Greco, A. and Gulino, A. (2011) Protected from the inside: endogenous histone deacetylase inhibitors and the road to cancer. Biochim. Biophys. Acta 1815, 241-252
4. Escande, C., Chini, C. C., Nin, V., Dykhouse, K. M., Novak, C. M., Levine, J., van Deursen, J., Gores, G. J., Lou, Z. and Chini, E. N. (2010) Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J. Clin. Invest. 120, 545-558
5. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., Rosenbaum, M., Zhao, Y., Gu, W., Farmer, S. R. and Accili, D. (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of PPARγ. Cell 150, 620-632
6. Kim, J. E., Chen, J. and Lou, Z. (2008) DBC1 is a negative regulator of SIRT1. Nature 451, 583-586 (Pubitemid 351186264)
7. Zhao, W., Kruse, J.-P., Tang, Y., Jung, S. Y., Qin, J. and Gu, W. (2008) Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451, 587-590 (Pubitemid 351186268)
8. Kim, W. and Kim, J. E. (2013) Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage. Cancer Lett. 333, 180-186
9. Park, S. H., Riley, P. 4th and Frisch, S. M. (2013) Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB. Apoptosis 18, 949-962
10. Garapaty, S., Xu, C. E., Trojer, P., Mahajan, M. A., Neubert, T. A. and Samuels, H. H. (2009) Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation. J. Biol. Chem. 284, 7542-7552
11. Fu, J., Jiang, J., Li, J., Wang, S., Shi, G., Feng, Q., White, E., Qin, J. and Wong, J. (2009) Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity. J. Biol. Chem. 284, 6832-6840
12. Koyama, S., Wada-Hiraike, O., Nakagawa, S., Tanikawa, M., Hiraike, H., Miyamoto, Y., Sone, K., Oda, K., Fukuhara, H., Nakagawa, K. et al. (2010) Repression of estrogen receptor beta function by putative tumor suppressor DBC1. Biochem. Biophys. Res. Commun. 392, 357-362
13. Trauemicht, A. M., Kim, S. J., Kim, N. H. and Boyer, T. G. (2008) Modulation of estrogen receptor α protein level and survival function by DBC1. Mol. Endocrinol. 21, 1526-1536 (Pubitemid 47001079)
14. Yu, E. J., Seok-Hyung, K., Heo, K., Ou, C.-Y., Stalicup, M. R. and Kim, J. H. (2011) Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy. Nucleic Acid Res. 39, 6932-6943
15. Chini, C. C., Escande, C., Nin, V. and Chini, E. N. (2013) DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbα. Biochem. J. 451, 453-461
16. Chini, C. C. S., Escande, C., Nin, V. and Chini, E. N. (2010) HDAC3 is negatively regulated by the nuclear protein DBC1. J. Biol. Chem. 285, 40830-40837
17. Li, Z., Chen, L., Kabra, N., Wang, C., Fang, J. and Chen, J. (2009) Inhibition of SUV39H1 Methyltransferase activity by DBC1. J. Biol. Chem. 284, 10361-10366
18. Kang, Y., Jung, W. Y., Lee, H., Lee, E., Kim, A. and Kim, B. H. (2012) Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma. Korean J. Pathol. 46, 523-531
19. Kim, S. H., Kim, J. H., Yu, E. J., Lee, K. W. and Park, C. K. (2012) The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis. Histol. Histopathol. 27, 49-58
20. Kim, J. E. and Sung, S. (2010) Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein. Neoplasma 57, 365-368
21. Hiraike, H., Wada-Hiraike, O., Nakagawa, S., Koyama, S., Miyamoto, Y., Sone, K., Tanikawa, M., Tsuruga, T., Nagasaka, K., Matsumoto, Y. et al. (2010) Identification of DBC1 as a transcriptional repressor for BRCA1. Br. J. Cancer 102, 1061-1067
22. Sung, J. Y., Kim, R., Kim, J. E. and Lee, J. (2010) Balance between SIRT1 and DBC1 expression is lost in breast cancer. Cancer Sci. 101, 1738-1744
23. Zhang, Y., Gu, Y., Sha, S., Kong, X., Zhu, H., Xu, B., Li, Y. and Wu, K. (2013) DBC1 is over-expressed and associated with poor prognosis in colorectal cancer. Int. J. Clin. Oncol., doi: 10.1007/s10147-012-0506-5
24. Cha, E. J., Noh, S. J., Kwon, K. S., Kim, C. Y., Park, B. H., Park, H. S., Lee, H., Chung, M. J., Kang, M. J., Lee, D. G. et al. (2009) Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin. Cancer Res. 15, 4453-4459
25. Bae, H. J., Chang, Y. G., Noh, J. H., Kim, J. K., Eun, J. W., Jung, K. H., Kim, M. G., Shen, Q., Ahn, Y. M., Kwon, S. H. et al. (2012) DBC1 does not function as a negative regulator of SIRT1 in liver cancer. Oncol. Lett. 4, 873-877
26. Hiraike, H., Wada-Hiraike, O., Nakagawa, S., Saji, S., Maeda, D., Miyamoto, Y., Sone, K., Tanikawa, M., Oda, K., Nakagawa, K. et al. (2011) Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer. Exp. Ther. Med. 2, 1105-1109
27. Anantharaman, V. and Aravind, L. (2008) Analysis of DBC1 and its homologs suggests a potential mechanism for regulation of sirtuin domain deacetylases by NAD metabolites. Cell Cycle 7, 1467-1472 (Pubitemid 351872586)
28. Close, P., East, P., Dirac-Svejstrup, A. B., Hartmann, H., Heron, M., Maslen, S., Chariot, A., Söding, J., Skehel, M. and Svejstrup, J. Q. (2010) DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. Nature 484, 386-389
29. Yin, L., Wu, N. and Lazar, M. A. (2010) Nuclear receptor Rev-erbα: a heme receptor that coordinates circadian rhythm and metabolism. Nucl. Recep. Signal. 8, 1-6
30. Alenghat, T., Meyers, K., Mullican, S. E., Leitner, K., Adeniji-Adele, A., Avila, J., Bucan, M., Ahima, R. S., Kaestner, K. H. and Lazar, M. A. (2008) Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456, 997-1000
31. Yin, L., Wu, N., Curtin, J. C., Qatanani, M., Szwergold, N. R., Reid, R. A., Waitt, G. M, Parks, D. J., Pearce, K. H., Wisely, B. and Lazar, M. A. (2007) Rev-erbα, a heme sensor that coordinates metabolic and circadian pathways. Science 318, 1786-1789 (Pubitemid 350274391)
32. Crumbley, C. and Burris, T. P. (2011) Direct regulation of CLOCK expression by REV-ERB. PloS ONE 6, e17290
33. Yin, L. and Lazar, M. A. (2005) The orphan nuclear Rev-erbα recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol. Endocrinol. 19, 1452-1459 (Pubitemid 41002977)
34. Feng, D. and Lazar, M. A. (2012) Clocks, metabolism, and epigenome. Cell 47, 158-167
35. Bugge, A., Feng, D., Everett, E. R., Mullica, S. E., Wang, F., Jager, J. and Lazar, M. A. (2012) Rev-erbα and Rev-erbβ coordinately protect the circadian clock and metabolic function. Genes Dev. 26, 657-667
36. Cho, H., Zhao, X., Hatori, M., Yu, R. T., Barish, G. D., Lam, M. T., Chong, L. W., Ditacchio, L., Atkins, A. R., Glass, C. K. et al. (2012) Regulation of circadian behavior and metabolism by Rev-erbα and Rev-erbβ. Nature 485, 123-127
37. Solt, L. A., Wang, Y., Baanerjee, S., Hughes, T., Kojetin, D. J., Lundasen, T., Shin, Y., Liu, J., Cameron, M. D., Noel, R. et al. (2012) Regulation of circadian behavior and metabolism by synthetic Rev-erb agonists. Nature 485, 62-68
38. Guarente, L. and Picard, F. (2005) Calorie restriction-The SIR2 connection. Cell 120, 473-482
39. Longo, V. D. and Kennedy, B. K. (2006) Sirtuins in ageing and age-related disease. Cell 126, 257-268
40. Bellet, M. M. and Sassone-Corsi, P. (2010) Mammalian circadian clock and metabolism-The epigenetic link. J. Cell Sci. 123, 3837-3848
41. Duez, H. and Staels, B. (2009) Rev-erb-alpha: an integrator of circadian rhythms and metabolism. J. Appl. Physiol. 107, 1972-1980
42. Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S. E., Alenghat, T., Liu, X. S. and Lazar, M. A. (2011) A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic liver metabolism. Science 331, 1315-1319
43. Lin, X., Zhang, S., Blander, G., Tse, J. G., Krieger, M. and Guarente, L. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell 28, 91-106 (Pubitemid 47531974)
44. Nerurkar, P. V. and Nerurkar, V. R. (2008) Can Sir(2) regulate cancer? Cell Sci. 4, 50-56
45. Baur, J. A. et al. (2010) Dietary restriction: Standing up for sirtuins. Science 329, 1012-1013
46. Nin, V., Escande, C., Chini, C. C., Giri, S., Camacho-Pereira, J., Matalonga, J., Lou, Z. and Chini, E. N. (2012) Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase. J. Biol. Chem. 287, 23489-23501
47. Kang, H., Suh, J. Y., Jung, Y. S., Jung, J. W., Kim, M. K. and Chung, J. H. (2011) Peptide switch is essential for Sirt1 deacetylase activity. Mol. Cell 44, 203-213
48. Suter, M. A., Chen, A., Burdine, M. S., Choudhury, M., Harris, R. A., Lane, R. H., Friedman, J. E., Grove, K. L., Tackett, A. J. and Aagaard, K. M. (2012) A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J. 26, 5106-5114
49. Raynes, R., Pombier, KM., Nguyen, K., Brunquell, J., Mendez, J. E. and Westerheide, S. D. (2013) The SIRT1 modulators AROS and DBC1 regulate HSF1 activity and the heat shock response. PLoS ONE 8, e54364
50. Yuan, J., Luo, K., Liu, T. and Lou, Z. (2012) Regulation of SIRT1 activity by genotoxic stress. Genes Dev. 26, 791-796
51. Zannini, L., Buscemi, G., Kim, J. E., Fontanella, E. and Delia, D. (2012) DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage. J. Mol. Cell Biol. 4, 294-303
52. Menssen, A., Hydbring, P., Kapelle, K., Vervoorts, J., Diebold, J., Lüscher, B., Larsson, L. G. and Hermeking, H. (2012) The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc. Natl. Acad. Sci. U.S.A. 109, E187-196
53. Guenther, M. G., Barak, O. and Lazar, M. A. (2001) The SMRT and N-CoR co-repressors are activating cofactors for histone deacetylase 3. Mol. Cell Biol. 21, 6091-6101 (Pubitemid 34263509)
54. Ishizuka, T. and Lazar, M. A. (2003) The NCoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol. Cell Biol. 23, 5122-5131 (Pubitemid 36950869)
55. Kamper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Kanamaluru, D., Tsang, S., Wu, S. Y., Chiang, C. M. and Veenstra, T. D. (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392-404
56. Green, C. D. and Han, J. D. (2011) Epigenetic regulation by nuclear receptors. Epigenomics 3, 59-72
57. Dai, Y., Ngo, D., Forman, L. W., Qin, D. C., Jacob, J. and Faller, D. V. (2007) Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol. Endocrinol. 21, 1807-1821 (Pubitemid 47173793)